Immunovant Inc. monthly returns
Immunovant Inc. has averaged 2.63% per month, positive in 46% of months. Month-by-month returns for Immunovant Inc. (IMVT) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Immunovant Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -20.9% | |
| Sep 2026 | -17.2% | |
| Aug 2026 | +5.7% | |
| Jul 2026 | +0.2% | |
| Jun 2026 | +15.7% | |
| May 2026 | +22.7% | |
| Apr 2026 | +9.3% | |
| Mar 2026 | -10.4% | |
| Feb 2026 | +6.7% | |
| Jan 2026 | +2.3% | |
| Dec 2025 | +5.3% | |
| Nov 2025 | -2.1% | |
| Oct 2025 | +53.1% | |
| Sep 2025 | +9.7% | |
| Aug 2025 | -8.6% | |
| Jul 2025 | +0.5% | |
| Jun 2025 | +7.7% | |
| May 2025 | -8.0% | |
| Apr 2025 | -5.5% | |
| Mar 2025 | -17.0% | |
| Feb 2025 | -5.2% | |
| Jan 2025 | -12.2% | |
| Dec 2024 | -12.2% | |
| Nov 2024 | -3.6% | |
| Oct 2024 | +2.6% | |
| Sep 2024 | -7.7% | |
| Aug 2024 | +6.3% | |
| Jul 2024 | +10.1% | |
| Jun 2024 | +4.0% | |
| May 2024 | -7.5% | |
| Apr 2024 | -15.1% | |
| Mar 2024 | -8.7% | |
| Feb 2024 | -2.9% | |
| Jan 2024 | -13.6% | |
| Dec 2023 | +7.7% | |
| Nov 2023 | +18.4% | |
| Oct 2023 | -13.9% | |
| Sep 2023 | +69.0% | |
| Aug 2023 | -0.5% | |
| Jul 2023 | +20.3% | |
| Jun 2023 | -9.7% | |
| May 2023 | +30.2% | |
| Apr 2023 | +4.1% | |
| Mar 2023 | -11.2% | |
| Feb 2023 | -1.7% | |
| Jan 2023 | +0.1% | |
| Dec 2022 | +35.4% | |
| Nov 2022 | +17.1% | |
| Oct 2022 | +100.7% | |
| Sep 2022 | +8.3% | |
| Aug 2022 | +25.0% | |
| Jul 2022 | +5.6% | |
| Jun 2022 | -8.0% | |
| May 2022 | -8.0% | |
| Apr 2022 | -16.3% | |
| Mar 2022 | -1.3% | |
| Feb 2022 | -20.2% | |
| Jan 2022 | -18.0% | |
| Dec 2021 | +10.6% | |
| Nov 2021 | -4.2% | |
| Oct 2021 | -7.5% | |
| Sep 2021 | +0.3% | |
| Aug 2021 | -17.2% | |
| Jul 2021 | -1.0% | |
| Jun 2021 | -30.3% | |
| May 2021 | -3.3% | |
| Apr 2021 | -2.2% | |
| Mar 2021 | +1.6% | |
| Feb 2021 | -59.6% | |
| Jan 2021 | -15.5% | |
| Dec 2020 | -6.1% | |
| Nov 2020 | +12.8% | |
| Oct 2020 | +24.0% | |
| Sep 2020 | +3.6% | |
| Aug 2020 | +50.2% | |
| Jul 2020 | -7.1% | |
| Jun 2020 | -5.1% | |
| May 2020 | +38.3% | |
| Apr 2020 | +19.2% | |
| Mar 2020 | -1.0% | |
| Feb 2020 | -0.4% | |
| Jan 2020 | -0.5% | |
| Dec 2019 | +51.9% | |
| Nov 2019 | +2.9% | |
| Oct 2019 | +1.4% | |
| Sep 2019 | +1.2% | |
| Aug 2019 | +1.1% | |
| Jul 2019 | -0.1% |
Monthly total return (since Nov 2021)#
Immunovant Inc. returns by calendar month#
Every month of every year since 2020, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -20.87% — 7th of 7 Octobers since 2020 at the last close; the average October returned +26.5%.
| Month | −105%0+105% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -8.2% | -12.2% | 29% | +2.3% 2026 | -18.0% 2022 | |
| Feb | -11.9% | -2.9% | 14% | +6.7% 2026 | -59.6% 2021 | |
| Mar | -6.9% | -8.7% | 14% | +1.6% 2021 | -17.0% 2025 | |
| Apr | -0.9% | -2.2% | 43% | +19.2% 2020 | -16.3% 2022 | |
| May | +9.2% | -3.3% | 43% | +38.3% 2020 | -8.0% 2025 | |
| Jun | -3.7% | -5.1% | 43% | +15.7% 2026 | -30.3% 2021 | |
| Jul | +4.1% | +0.5% | 71% | +20.3% 2023 | -7.1% 2020 | |
| Aug | +8.7% | +5.7% | 57% | +50.2% 2020 | -17.2% 2021 | |
| Sep | +9.4% | +3.6% | 71% | +69.0% 2023 | -17.2% 2026 | |
| Oct | +26.5% | +13.3% | 67% | +100.7% 2022 | -13.9% 2023 | |
| Nov | +6.4% | +5.3% | 50% | +18.4% 2023 | -4.2% 2021 | |
| Dec | +6.8% | +6.5% | 67% | +35.4% 2022 | -12.2% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from IMVT's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Immunovant Inc.'s average monthly return?
- Immunovant Inc. (IMVT) has averaged about 2.63% per month, positive in roughly 46% of months. The best month was Oct 2022 (+100.7%) and the worst was Feb 2021 (-59.6%).